The identification of molecular mechanisms and a new biomarker of pancreatic cancer with glucose intolerance.

The identification of molecular mechanisms and a new biomarker of pancreatic cancer with glucose intolerance. - The identification of molecular mechanisms and a new biomarker of pancreatic cancer with glucose intolerance.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024977

Enrollment

Registered

2016-11-24

Start date

2016-11-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer, Diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Pancreatic cancer patients who undergo a pancreatectomy operation in our hospital. 2.Pancreatic cancer without chemotherapy and radiation therapy.

Exclusion criteria

Exclusion criteria: 1.Benign pancreatic disorder 2.Type 1 diabetes 3.Chronic pancreatitis

Design outcomes

Primary

Measure	Time frame
Expression profile of coding and non- coding RNA obtained from pancreatic cancer patients' blood and surgical specimen.	—

Countries

Japan

Contacts

Public ContactHiroko Takahashi

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Nephrology, Rheumatology, Endocrinology and Metabolism

hirokotakahashi@okayama-u.ac.jp086-235-7235

Outcome results